Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 27,460 shares at $11.03 ($303K) on 2016-11-09, disclosed to the SEC on 2016-11-10.
Open-market sale of $303k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.03 | 13,730 | $151K | 50.0% |
| 2 | $11.03 | 13,730 | $151K | 50.0% |
| Total | $11.03 avg | 27,460 | $303K | 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |